Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer

被引:41
作者
Huang, HJ
Neven, P
Drijkoningen, M
Paridaens, R
Wildiers, H
Van Limbergen, E
Berteloot, P
Amant, F
Vergote, I
Christiaens, MR
机构
[1] Katholieke Univ Leuven Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Louvain, Belgium
[2] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Taoyuan, Taiwan
[3] Katholieke Univ Leuven Hosp, Multidisciplinary Breast Ctr, B-3000 Louvain, Belgium
[4] Katholieke Univ Leuven Hosp, Dept Pathol, B-3000 Louvain, Belgium
[5] Katholieke Univ Leuven Hosp, Dept Med Oncol, B-3000 Louvain, Belgium
[6] Katholieke Univ Leuven Hosp, Dept Radiooncol, B-3000 Louvain, Belgium
[7] Katholieke Univ Leuven Hosp, Dept Surg, B-3000 Louvain, Belgium
关键词
estrogen receptor; progesterone receptor; HER2/neu; breast tumours;
D O I
10.1093/annonc/mdi364
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In breast cancer, there is an inverse relationship between HER2/neu overexpression and receptors for estrogen (ER) or progesterone (PR). Some clinical observations such as the age-related association between hormone receptors and tumour grade, which predicts HER2/neu overexpression, suggest an age-related relationship. Patients and methods: Our study population consisted of 1362 consecutive women receiving primary surgery for non-metastatic invasive breast cancer. We compared the relationship between both hormone receptors and HER2/neu overexpression in different age groups taking other tumour characteristics into account. Results: In a multivariate model, considering the overall group, a negative ER, a negative PR and a high tumour grade were predictive for HER2/neu overexpression (P < 0.001). Considering 246 women aged <= 45 years, the only predictor for HER2/neu overexpression in this age category was a high tumour grade (P = 0.003). Considering the 1116 women aged > 45 years, ER (P = 0.001), PR (P = 0.001) and tumour grade (P < 0.001) were associated with HER2/neu (P < 0.001). Conclusion: Our findings indicate that the association between ER, PR and HER2/neu overexpression varies with age. The hormone receptors are not an independent predictor for the HER2/neu status in young women while they are in elder patients.
引用
收藏
页码:1755 / 1761
页数:7
相关论文
共 31 条
[1]   THE PRODUCT OF THE HUMAN C-ERBB-2 GENE - A 185-KILODALTON GLYCOPROTEIN WITH TYROSINE KINASE-ACTIVITY [J].
AKIYAMA, T ;
SUDO, C ;
OGAWARA, H ;
TOYOSHIMA, K ;
YAMAMOTO, T .
SCIENCE, 1986, 232 (4758) :1644-1646
[2]  
Albain K S, 1994, J Natl Cancer Inst Monogr, P35
[3]   ESTROGEN-DEPENDENT, TAMOXIFEN-RESISTANT TUMORIGENIC GROWTH OF MCF-7 CELLS TRANSFECTED WITH HER2/NEU [J].
BENZ, CC ;
SCOTT, GK ;
SARUP, JC ;
JOHNSON, RM ;
TRIPATHY, D ;
CORONADO, E ;
SHEPARD, HM ;
OSBORNE, CK .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 24 (02) :85-95
[4]   IMMUNOHISTOCHEMICAL ANALYSIS OF P53 AND HER-2/NEU PROTEINS IN HUMAN TUMORS [J].
CHANG, K ;
DING, I ;
KERN, FG ;
WILLINGHAM, MC .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1991, 39 (09) :1281-1287
[5]   Should selection of adjuvant chemotherapy for patients with breast cancer be based on erbB-2 status? [J].
Clark, GM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1320-1321
[6]   Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer:: Evidence from a phase III randomized trial [J].
Ellis, MJ ;
Coop, A ;
Singh, B ;
Mauriac, L ;
Llombert-Cussac, A ;
Jänicke, F ;
Miller, WR ;
Evans, DB ;
Dugan, M ;
Brady, C ;
Quebe-Fehling, E ;
Borgs, M .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) :3808-3816
[7]  
ELSTON CW, 1993, J CLIN PATHOL, V46, P189
[8]  
Fisher E R, 1981, Breast Cancer Res Treat, V1, P37, DOI 10.1007/BF01807890
[9]   Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related [J].
Huang, HJ ;
Neven, P ;
Drijkoningen, M ;
Paridaens, R ;
Wildiers, H ;
Van Limbergen, E ;
Berteloot, P ;
Amant, F ;
Christiaens, MR ;
Vergote, I .
BREAST CANCER RESEARCH AND TREATMENT, 2005, 91 (01) :81-87
[10]   Quantitative association between, HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer [J].
Konecny, G ;
Pauletti, G ;
Pegram, M ;
Untch, M ;
Dandekar, S ;
Aguilar, Z ;
Wilson, C ;
Rong, HM ;
Bauerfeind, I ;
Felber, M ;
Wang, HJ ;
Beryt, M ;
Seshadri, R ;
Hepp, H ;
Slamon, DJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (02) :142-153